MannKind is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer.
STAY TUNED
AFRESA™ (pronounced uh-FRESS-uh) is the trade name proposed to the US Food and Drug Administration for our Technosphere® Insulin System.
Work on treatments with the potential for worldwide impact, and help create a better world inside: find a career at MannKind
| STOCK | PRICE | CHANGE | %CHANGE |
| MNKD | 3.50 |  0.20 | 6.06% |
| Nov 20 2008 4:00PM | 20 min. delay | ||
